Q2 2020 CellaVision AB Earnings Call Transcript
Ladies and gentlemen, welcome to the CellaVision AB Q2 report for 2020. Today, I'm pleased to present the CEO, Zlatko Rihter. (Operator Instructions) Mr. Rihter, please begin.
()-&
Thank you very much, and welcome, everybody, to the quarter 2 report from CellaVision. With me today -- so I'm Zlatko Rihter, the CEO. I also have me Maria Morin, she's heading the HR and Corporate Communications for CellaVision; and Magnus Blixt, CFO. So we hope that we can address all types of questions that might pop up later.
But first of all, I will walk you through the numbers and also a little bit, of course, our strategy and so on as usual. And I suggest that we move to Slide #3. And of course, our vision, as before, is to be the global leader within digitalization, automatization of the blood analysis. We offer a method that really contributes to both improve diagnostics, but also efficiency in labs. And our primary target or call point at this time is the hematology
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |